Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy

Cellular and Molecular Biology

Volumn 53, Issue 5, 2007, Pages 68-78

  Dave, G S ^b   Kalia, K ^a  

^a SARDAR PATEL UNIVERSITY   (India)

^b NONE

Author keywords

Nephropathy; Oxidative stress; Type 1 and type 2 diabetes mellitus

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME REGULATION; ERYTHROCYTE; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; AGED; BLOOD; DIABETIC NEUROPATHY; METABOLISM; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS;

ADULT; AGED; CATALASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ERYTHROCYTES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REGRESSION ANALYSIS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 34447283547     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T820     Document Type: Article

References (50)

1. Andersen, A.R., Christiansen, J.S., Andersen, J.K., Kreiner, S., Deckert, T., Diabetic nephropathy in type-1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983, 25: 496-501.
2. Aronson, D., Rayfield, E.J., How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol. 1 (2002) 1, Epub April 2002, 08.
3. Atalay, M. and Laaksonen, D.E., Diabetes, oxidative stress and physical exercise. Journal of Sports Science and Medicine 2002, 1: 1-14.
4. Avissar, N., Ornt, D.B., Yagil, Y., Horowitz, S., Watkins, R.H., Kerl, E.A. Takahashi, K., Palmer I.S. and Cohen, H.J., Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am. J. Physiol. 1994, 266: C367-C375.
5. Bhatia, S., Shukla, R., Venkata S.M., Gambhir, J.K. and Prabhu, K.M., Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin. Biochem. 2003, 36: 557-562.
6. Bonnefont-Rousselor, D., Glucose and reactive oxygen species. Curr. Opin. Nutr. Metab. Care 2002, 5: 561-568.
7. Buege, J.A. and Aust, S.D., Microsomal lipid peroxidation. Methods Enzymol. 1978, 52: 302-305.
8. Carmeli, E., Coleman, R. and Berner, Y.N., Activities of antioxidant scavenger enzymes (Superoxide Dismutase and Glutathione Peroxidase) in erythrocytes in adult women with and without Type II diabetes. Exp. Diab. Res. 2004, 5: 171-175.
9. nd Ed., Alberti, K., Zimmet, P., De Fronzo R.A. (Eds.), Chichester, U.K., John Wiley & Sons, New York, 1997, pp.1453-1461.
10. Ceriello, A., Morocutti, A., Mercuri, F., Quagliaro, L., Moro, M., Damante, G. and Viberti, G.C., Defective intracellular antioxidant enzyme production in Type 1 diabetic patients with nephropathy. Diabetes 2000, 49: 2170-2177.
11. Colak, E., Majkic-singh, N., Stankovic, S., Sreckovic-Dimitrijevic, V., Djordjevic, P.B., Lalic, K. and Lalic, N., Parameters of antioxidative defence in type-2 diabetic patients with cardiovascular complications. Annals of Medicine 2005, 37: 613-620.
12. Creager, M.A., Luscher, T.F., Cosentino, F. and Beckman, J.A., Diabetes and vascular Disease: Pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003, 108: 1527-1532.
13. Darmaun, D., Smith, S.D., Sweeten, S., Sager, B.K., Welch, S. and Mauras, N., Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type-1 diabetes. Diabetes 2005, 54: 190-196.
14. Dinser, Y., Alademir, A., Ilkova, H. and Aksay, T., Susceptibility of glutathione and glutathione-related antioxidant activity to hydrogen peroxide in patient with type 2 diabetes: effect of glycemic control. Clin. Biochem. 2002, 35: 297-301.
15. Du, X., Edelstein, D., Rossetti, L., Goldberg, I.G.F., Ziyadeh, F., Wu. J. and Brownlee, M., Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. USA 2000, 97: 12222-12226.
16. Ellman, G.L., Tissue sulfhydryl groups. Arch. Biochem. 1959, 82: 70-77.
17. Evans, J.E., Goldfine, I.D. Muddux, B.A. and Grodsky, G.M. Oxidative stress and stress-activated signaling pathways: aunifying htpothesis of type-2 diabetes. Endocrine Rev. 2002, 23: 599-622.
18. Flohe, L. and Gunzler, W.A., Assays of glutathione peroxidase. Methods Ezymol. 1984, 105: 114-121.
19. George, L.K. and Mary R.L., Hyperglycemia-induced oxidative stress in diabetic complications. Histochem. Cell. Biol. 2004, 122: 333-338.
20. Gokkusu, C., Palanduz, S., Ademoglu, E. and Tamer, S., Oxidant and antioxidant systems in NIDDM patients: influence of vitamin E supplementation. Endocrine Research 2001, 27: 377-386.
21. Hartnett, M.E., Stratton, R.D., Browne, R.W., Rosner, B.A., Lahman, R.J. and Armstrong, D., Serum markers of oxidative and severity of diabetic retinopathy. Diab. Care 2000, 23: 234-240.
22. Hartnett, M.E., Stratton, R.D., Browne, R.W., Rosner, B.A., Lanham, R.J., Armstrong, D., Serum markers of oxidative stress and severity of diabetic retinopathy. Diab. Care 2000, 23: 234-240.
23. Jain, S.K. and McVie, R., Hyperketonemia can increased lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in Type 1 diabetic patients. Diabetes 1999, 48(8) 1850-1854.
24. Jain, S.K., McVie, R. and Tiney, S., Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diab. Care 2000, 23: 1389-1394.
25. Jollow, D.J., Mitchell, J.R., Zamppaglione, Z. and Gillette, J.R., Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolites. Pharmacol. 1974, 11: 151-156.
26. Joseph, L.E., Ira, D.G., Maddux, B.A. and Grodsky, G.M.. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of Type 2 diabetes. Endocrine Rev. 2002, 23: 599-562.
27. Jurek, A., Turyna, B., Kubit, P. and Klein, A., LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure. Clin. Biochem. 2006, 39: 19-27.
28. Kalia, K., Sharma, S. and Mistry, K., Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy. Clin. Chim. Acta 2004, 347: 169-176.
29. Kesavulu, M.M., Giri, R., Rao, B.K. and Apparao, C., Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diab. Metab. 2000, 26: 387-392.
30. Kesavulu, M.M., Rao, B.K., Giri, R., Vijaya, J., Subramanyam G. and Apparao, C., Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diab. Res. Clin. Prac. 2001, 53: 33-39.
31. Kohen, R. and Nyska, A., Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic pathol. 2002, 30: 620-650.
32. Krowleski, A.S., Warram, J.H., Chriestlieb, A.R., Busick, E.J., Kahn, C.R., The changing natural history of nephropathy in type-1 diabetes. Am. J. Med. 1985, 78: 785-794.
33. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., J. Bio. Chem. 1951, 193: 255-59.
34. Matteucci, E. and Giampietro, O., Oxidative stress in families of Type 1 diabetic pateints. Diab. Care 2000, 23: 1182-1185.
35. Michael, B., Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414: 813-820.
36. Migdalis, I.N., Kalogeropoulou, K., Iliopoulou, V., Triantafilou, P., Charalabides, J., Mortzos, G. and Cordopatis, C., Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy. Diab. Res. Clin. Pract. 2001, 54: 129-136.
37. Oyama, T., Miyasita, Y., Watanabe, H. and Shirai, K., The role of Polyol pathway in high glucose-induced endothelial cell damage. Diab. Res. Clin. Pract. 2006, article in press.
38. Ozden, M., Maral, H., Akaydin, D., Cetinalp, P. and Kalender, B., Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin. Biochem. 2002, 35: 269-273.
39. Programme for appropriate technology in health (PATH), anemia detection in health services: Guidelines for Programme managers, Washington. US Agency for International Development 1996, pp. 37.
40. Ruiz, C., Alegria, A., Barbera, R., Farre, R. and Lagarda, M.J., Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand. J. Clin. Lab. Invest. 1999, 59: 99-106.
41. Sinha, A.K., Colorimetric assay of catalase. Anal. Biochem. 1972, 47: 389-394.
42. Sundaram, R.K., Bhaskar, A., Vijayalingam, S., Viswanathan, M., Mohan, R. and Shanmugasundaram, K.R., Antioxidant status and lipid peroxidation in type 2 diabetes mellitus with and without complications. Clin. Sci. 1996, 90: 255-260.
43. Suji, G. and Sivakami, S., Approaches to the treatment of diabetes mellitus: An overview. Cell. Mol. Biol. 2003, 49: 635-640.
44. Tan, K.C., Chow, W.S. Ai, V.H. Metz, C., Bucala, R. and Lam, K.S., Advanced glycosylation end products and endothelial dysfunction in type-2 diabetes. Diab. Care 2002, 25: 1055-1059.
45. Telci, A., Cakatay, U., Salman, S., Satman, I. and Sivas, A., Oxidative protein damage in early stage type 1 diabetic patients. Diab. Res. Clin. Prac. 2000, 50: 213-223.
46. The Diabetes Control and Complication Trials (DCCT) Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329: 977-986.
47. Turk H.M., Sevic, A., Camci, C., Cigli, A., Buyukberber, S., Savli, H. and Bayraktar, N., Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol. 2002, 39: 117-122.
48. Vijayalingam, S., Parthiban, A., Shanmugasundaram, K.R. and Mohan, V., Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diab. Med. 1996, 13: 1589-1593.
49. Yessoufou, A., Moutairou, K., Girard, A., Fatoke, M., Prost, J., Ahissou, H., Djrolo, F., Avode, G., Amoussouguenou, D., Hichami, A. and Khan, N.A., Antioxidant status in alcohol-related diabetes mellitus in Beninese subjects. Cell. Mol. Biol. 2005, 51: OL849-OL858.
50. Zrrouni, K., Nourooz-Zadeh, J., Harry, D., Kerry, S.M., Betteridge, D.J., Cappuccio, F.P. and Earle, K.A., Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes. Diab. Care 2005, 28: 1698-1703.